Protein Intake Patterns for Obesity Management
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine whether the timing of protein intake affects energy use and if a high-protein breakfast can reduce snack cravings. Participants will follow one of two eating plans: one with protein spread evenly across meals (even protein) and the other with most protein at dinner (skewed protein). The study seeks individuals with a BMI (a measure of body fat) below 25 or between 30 and 34.5, who maintain stable eating and activity habits, and are free from major illnesses. As an unphased trial, it offers a unique opportunity to contribute to understanding dietary impacts on energy use and cravings.
Will I have to stop taking my current medications?
The trial requires that you do not take medications known to affect energy expenditure and appetite.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that changing the timing of protein intake might aid in weight and fat loss. Studies have found that distributing protein evenly across breakfast, lunch, and dinner can support weight loss on certain diets.
However, consuming most protein at dinner does not significantly impact muscle or body changes compared to spreading it out. This suggests that protein timing might not be crucial for altering body shape.
Importantly, both methods of protein consumption—spreading it out or concentrating it at dinner—have been studied and are generally safe, with no serious side effects reported. Both approaches are usually well-tolerated by individuals.12345Why are researchers excited about this trial?
Researchers are excited about the Protein Intake Patterns for Obesity Management trial because it explores how the timing and distribution of protein intake could impact weight management. Unlike typical obesity treatments that often rely on medication or calorie restriction, this trial focuses on dietary patterns. The "Even protein" approach offers a balanced 30 grams of protein at each meal, while the "Skewed protein" option provides most of the protein at dinner. This trial could reveal if protein distribution throughout the day influences weight loss differently, offering a new angle for managing obesity through diet.
What evidence suggests that this trial's treatments could be effective for obesity management?
This trial will compare two protein intake patterns for obesity management: an even protein distribution and a skewed protein distribution. Studies have shown that spreading protein intake evenly throughout the day can aid in weight and fat loss. Research indicates that consuming about 30 grams of protein at each meal helps maintain muscle and can lead to a greater reduction in body mass index (BMI) and belly fat. In contrast, consuming most protein at dinner, as in the skewed protein arm of this trial, does not significantly change body composition during weight loss. Evidence suggests that distributing protein evenly across meals may be more effective for managing obesity and improving body shape.12346
Who Is on the Research Team?
Shanon Casperson, PhD
Principal Investigator
USDA Grand Forks Human Nutrition Research Center
Are You a Good Fit for This Trial?
This trial is for adults with a BMI < 25 or between 30-34.5, who are generally healthy and have not had significant weight changes recently. Women of childbearing age must use birth control and have regular cycles. Participants should eat normal amounts of protein and maintain consistent activity levels.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants consume either an even or skewed distribution of protein across meals to assess effects on energy metabolism and snacking behavior
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Even protein
- Skewed protein
Find a Clinic Near You
Who Is Running the Clinical Trial?
USDA Grand Forks Human Nutrition Research Center
Lead Sponsor